Search
Now showing items 1-10 of 21
Triple-negative breast cancer: the reality in Chile and in Latin America
(2019)
Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, ...
Triple-negative breast cancer: the reality in Chile and in Latin America
(Facultad de Medicina y Ciencia, 2019)
Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, ...
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(Spandidos Publications, 2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(Spandidos Publications, 2019)
Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
(2018)
B7-H4 (VTCN1) is a member of the CD28/B7 family of immune co-inhibitory molecules. The relationship of tumor and stromal B7-H4 protein expression with PD-L1, tumor infiltrating lymphocytes (TILs) and its association with ...
Systemic immune mediators reflect tumor-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast câncer
(Blackwell Scientific Publications, 2023)
Systemic immune mediators reflect tumor-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast câncer
(Blackwell Scientific Publications, 2023)
Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells
(2022)
Triple-negative breast cancer (TNBC) represents a challenge in the search for new therapeutic targets. TNBCs are aggressive and generate resistance to chemotherapy. Tumors of TNBC patients with poor prognosis present a ...